EUROMED AG
EUROMED AG english
Ad hoc announcement transmitted by DGAP.
The issuer is solely responsible for the content of this announcement.
——————————————————————————–
EUROMED AG Publishes Preliminary Results for the First Half of 2001
Positive Earnings Development – Executive Board Confirms Projections for the
Entire Year
Fürth, July 26, 2001 – According to preliminary calculations, EUROMED AG was
able to increase its sales by 29% in the first half of 2001 as compared to the
same period in the previous year, reaching a total of DM 20.2 million. The
preliminary earnings before interest and taxes (EBIT) are positive at DM 1.6
million, and in comparison to the prior-year period improved by DM 2.5 million.
Decisive factors in this favorable development were the resumption of
uninterrupted clinic operation at the Fürth location after the completion of
construction work there and the fact that EUROMED successfully changed its
field of specialization. The fully consolidated subsidiary ENTACON, which
provides consulting services with an emphasis on quality management, was also
able to play a role to this development. At DM 0.4 million, its adjusted
contribution to sales was significantly higher than in the prior year.
The Executive Board remains confident that the projections made at the
beginning of the year for the entire year 2001 are accurate and that sales will
grow by about 22% to approximately DM 37 million while earnings will clearly be
positive.
The final figures will be published on August 16, 2001.
Contact:
Michael Wünsche, Member of the Executive Board of Euromed AG,
Tel: +49/911-97 14 600, Fax: 0911-9714 607, e-mail: wuensche@euromed.de
http://www.euromed.de
end of ad hoc announcement (c) DGAP 26.07.2001
——————————————————————————–
WKN: 570680; Index:
Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin, Bremen, Düsseldorf,
Hamburg, Hannover, München und Stuttgart
260730 Jul 01
Latest News
Latest Reports
No Reports found
Upcoming Events
No Events found
Webcasts
No Webcasts found